Human Mast Cell Line (LAD2) ; Capable of histamine release (degranulation)

Cat. No.
T8157
Unit
1x106 cells / 1.0 ml
Price
Inquiry

Worried about losing your cells due to growth or thawing difficulties, or even a random freezer breakdown? Enjoy peace of mind knowing that you can be covered under abm's Cell Line Insurance.

Sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchasing institution.

For for-profit organizations, please contact quotes@abmgood.com for pricing.

Cat. No. T8157
Name Human Mast Cell Line (LAD2) ; Capable of histamine release (degranulation)
Description

The LAD2 human mast cell line originates from bone marrow aspirates of a patient with mast cell sarcoma/leukemia. These cells exhibit ultrastructural characteristics of human mast cells and express FcεRI, along with markers such as CD4, 9, 13, 14, 22, 31, 32, 45, 64, 71, 103, 117, 132, CXCR4 (CD184), and CCR5 (CD195). Additionally, they contain intracytoplasmic histamine, tryptase, and chymase. Notably, LAD2 cells do not carry activating mutations at codon 816 of the c-kit gene. Similar to LAD1, LAD2 cells release β-hexosaminidase upon FcεRI or FcϒRI aggregation.

The availability of the LAD2 mast cell line provides a unique opportunity to study the biology of human mast cells. Over time, it has become the most widely used and recognized gold-standard mast cell line for allergy and mastocytosis research, as well as a crucial tool in pharmaceutical development.

Organism Human (H. sapiens)
Tissue Bone Marrow
Donor History Male, 44, Mastocytosis
Growth Properties

Suspension; Rounded, granulated; some large aggregates at higher densities

Cell Type Tumor Cells
Unit 1x106 cells / 1.0 ml
Storage Condition Vapor phase of liquid nitrogen, or below -130°C.
Shipping Conditions

Ship with dry ice.

Product Format Frozen
Intended Use This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use.
BioSafety II
Certificate of Analysis For batch-specific test results, refer to the applicable certificate of analysis that can be found at www.abmgood.com.
Growth Conditions

PriCoat™ T25 Flasks (G299) are recommended for optimal cell culture. PriGrow X Series Medium for T8157 (TM8157) + 100ng/ml human Stem Cell Factor (Z100815) + 2mM L-Glutamine (G275) + 1% Penicillin/Streptomycin Solution (G255), 37.0°C, 5% CO₂. 

Replace half of the medium with an equal volume of fresh medium, weekly. Do not allow cells to become over-confluent or grow past a density of 1x106 cells/ml. 

Note: it is normal to observe cell death in the first two weeks after thawing. Allow cells to recover under the recommended culture conditons. Cells are slow-growing and extremely sensitive to mycoplasma contamination; routine testing should be performed. 

*Cells may lose functionality as a result of continuous culture. Degranulation assays must be conducted every 2 months to test functionality -protocol can be found under the "Documents" tab. 

Unpacking and Storage Instructions

1. Visually examine the packaging containers for signs of leakage or breakage.

2. Immediately transfer frozen cells from dry ice packaging to a temperature below -130°C, preferably in liquid nitrogen vapor phase storage, until ready for use.

To ensure the highest level of viability, thaw the vial and initiate culture as soon as possible upon receipt. If continued storage is desired, the vial should only be stored below -130°C or in liquid nitrogen vapor phase. Do not store at -70°C, as it will result in loss of viability.

 

Thawing Protocol

1. Thaw cells quickly in a 37°C water bath while agitating gently (maximum 2 minutes). The vial cap should be kept above the water level to minimize the risk of contamination.

2. Decontaminate the vial by spraying and wiping the exterior of the vial with 70% ethanol. From this point onwards, all operations should be strictly carried out inside a biological safety cabinet using aseptic conditions.

3. Transfer the cell suspension into a 15ml sterile conical tube containing 5ml of pre-warmed, complete growth media. Centrifuge cells at 850rpm for 5 minutes.

4. Aspirate the supernatant without disturbing the cell pellet. Re-suspend the cell pellet in the recommended pre-warmed, complete growth media and dispense into a T25 culture flask.

5. Incubate the cells at the recommended conditions.

6. Post-thaw viability should be 70-95%; however, it is normal to observe increased cell death and debris in the first two-three weeks after the post-thaw period. Remove debris and dead cells during this period by skimming, where possible. Hemidepletion of the media should be performed 1-2 times per week depending on cell density. Allow cells to recover during the first 2-4 weeks post-thaw. In addition, add fresh 100 ng/ml SCF 1-2 times per week.

Subculture Protocol

1. Transfer expanding cultures to T75 or larger culture vessels to keep cell densities between 5x105 - 8x105 cells/ml. Do not exceed a density of 1x106 cells/ml. 

2. Remove half the volume of the culture media and replace with fresh media (hemidepletion) the first or second week after thawing. Remove debris by skimming media, if possible. It is normal to see increased cell death for the first 2-3 weeks following thawing.

3. Alternatively, collect cells and centrifuge (850 rpm for 5 min ) to form a pellet. Discard half the supernatant and re-suspend the cell pellet in the remaining media. Add fresh complete media in 1:1 ratio and aliquot the cell suspension to new culture vessels, as desired. A complete media change is not advised

4. Incubate the cells at the recommended conditions.

Cryopreservation

Following centrifugation, leave a small amount of culturing media (50-100 uL). Suspend cells in non-DMSO, non-FBS containing CryoScarless Cryopreservative (BioVerde) at a final concentration of 5x106 cells/mL. Place vials in a cryo container and store at -80°C or in liquid nitrogen for longer preservation.

Seeding Density (cells/ml) 500,000-800,000
Population Doubling Time (h) Initially grow slowly; double in 2-4 weeks under optimal conditions.
Expression

FcεRI, CD33, CD34, CD63, CD117, CD133, CD193

STR Profiling

D5S818 : 10,11

D13S317 : 10,12

D7S820 : 11,11

D16S539 : 11,13

VWA : 15,18

TH01 : 7,7

AMEL : X,Y

TPOX : 11,11

CSF1PO : 9,10

D12S391 : 18,22

FGA : 23,24

D2S1338 : 17,21

D21S11 : 32.2,33.2

D18S51 : 13,14

D8S1179 : 13,14

D3S1358 : 16,19

D6S1043 : 12,14

PENTAE : 5,10

D19S433 : 13,15

PENTAD : 13,14

D1S1656 : 15,17.3

Warranty abm warrants that cell lines shall be viable upon initiation of culture for a period of thirty (30) days after shipment and that they shall meet the specifications on the applicable abm Material Product Information sheet, certificate of analysis, and/or catalog description. Such thirty (30) day period is referred to herein as the "Warranty Period”.
Disclaimer

1. Sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchasing individual/institution for each order. If you have any questions regarding this, please contact us at licensing@abmgood.com.

2. All test parameters provided in the CoA are conducted using abm's standardized culture system and procedures. The stated values may vary under the end-user's culture conditions. Please verify that the product is suitable for your studies by referencing published papers or ordering RNA (0.5 μg, Cat.# C207, $450.00) or cell lysate (100 μg, Cat.# C206, $600.00) to perform preliminary experiments, or alternatively use our Gene Expression Assay Service (Cat# C138). All sales are final.

3. We recommend live cell shipments for ease of cell transfer and this option can be requested at the time of ordering. Please note that the end-user will need to evaluate the feasibility of live cell shipment by taking into account the final destination's temperature variation and its geographical location. In addition, we thoroughly test our cell lines for freeze-thaw recovery. If frozen cells were received and not recovered in your lab under the exact, specified conditions (using recommended culture vessel, media, additional supplements, and atmospheric conditions), a live cell replacement is possible at a cost (plus shipping).

4. All of abm's cell biology products are for research use ONLY and NOT for therapeutic/diagnostic applications. abm is not liable for any repercussions arising from the use of its cell biology product(s) in therapeutic/diagnostic application(s). Please contact a technical service representative for more information.

5. abm makes no warranties or representations as to the accuracy of the information on this site. Citations from literature and provided for informational purposes only. abm does not warrant that such information has been shown to be accurate.

6. abm warrants that cell lines shall be viable upon initiation of culture for a period of thirty (30) days after shipment and that they shall meet the specifications on the applicable abm Material Product Information sheet, certificate of analysis, and/or catalog description. Such thirty (30) day period is referred to herein as the "Warranty Period."

Depositor NIH (NIAID)
Application

Research Use Only.

Material Citation If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. T8157
Print/Download Datasheet
  • Kirshenbaum, A. S., Akin, C., Wu, Y., Rottem, M., Goff, J. P., Beaven, M. A., ... & Metcalfe, D. D. (2003). Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI. Leukemia research, 27(8), 677-682.


    S. Kirshenbaum, A., Yin, Y., Sundstrom, J. B., Bandara, G., & D. Metcalfe, D. (2019). Description and characterization of a novel human mast cell line for scientific study. International Journal of Molecular Sciences, 20(22), 5520.

This product has no review yet.
Other Cell Lines
SEARCH RESULT